The latest price target for Aspen Aerogels (NYSE:ASPN) was reported by Barclays on November 12, 2024. The analyst firm set a price target for $25.00 expecting ASPN to rise to within 12 months (a possible 108.68% upside). 26 analyst firms have reported ratings in the last year.

The latest analyst rating for Aspen Aerogels (NYSE:ASPN) was provided by Barclays, and Aspen Aerogels maintained their overweight rating.

The last upgrade for Aspen Aerogels Inc happened on March 20, 2023 when Benchmark raised their price target to $14. Benchmark previously had a hold for Aspen Aerogels Inc.

There is no last downgrade for Aspen Aerogels.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Aspen Aerogels, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Aspen Aerogels was filed on November 12, 2024 so you should expect the next rating to be made available sometime around November 12, 2025.

While ratings are subjective and will change, the latest Aspen Aerogels (ASPN) rating was a maintained with a price target of $27.00 to $25.00. The current price Aspen Aerogels (ASPN) is trading at is $11.98, which is out of the analyst’s predicted range.